All Biotech News

List of articles in category All Biotech News
Title	Published Date
Byondis Initiates Phase I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib in HER2-Expressing Solid Tumors	08/25/2020
New Nasal Gel Evaluated for its Protective Action Against Human Rhinovirus 16 (HRV-A16) Infection in Nasal Epithelial Cells	08/24/2020
MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US	08/24/2020
Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19	08/20/2020
Byondis Announces Appointment of Chief Financial Officer	08/19/2020
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875	08/11/2020
Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication	08/11/2020
A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels	07/29/2020
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine	07/29/2020
Digital Health: Clinical Study Published in “Ophthalmology” Demonstrates Implandata’s EYEMATE System Benefits Glaucoma Patients	07/27/2020
MC2 Therapeutics Announces U.S. Food and Drug Administration Approval of Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis	07/22/2020
Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer	07/15/2020
SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors	07/14/2020
Toxys Appoints Susan Swarte as New Non-Executive Board Member	07/14/2020
Vetter Further Expands its Development Service with New Site in Austria	07/08/2020
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market	07/06/2020
Immune Regulation Ltd Partners with DynPort Vaccine Company to Advance its Drug Product for COVID-19 into Clinical Trials	07/06/2020
osteolabs GmbH Provides Further Validation for Use of OsteoTest in Osteoporosis and Early-Stage Kidney Malfunction	07/02/2020
SOTIO Appoints Richard Sachse as Chief Medical Officer	07/01/2020
US FDA Grants Orphan Drug Designation (ODD) for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer	06/30/2020
Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies	06/25/2020
BioGeneration Ventures Closes BGV IV Fund at €105 Million	06/24/2020
First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients	06/23/2020
SOTIO Presents New Data Showing Strong Anti-tumor Effect of IL-15 Superagonist SO-C101 in Mice at 2020 AACR Virtual Annual Meeting II	06/22/2020
Happy 25-Years Anniversary And a New Era of Pharma Partnering	06/22/2020
arivis Unveils Multiuser VR For Volumetric Imaging	06/16/2020
SOTIO to Present New Preclinical Data on IL-15 Superagonist, SO-C101, at the 2020 AACR Virtual Annual Meeting II	06/15/2020
ZZ Biotech Announces FDA Fast Track Designation for Stroke Program	06/12/2020
Ophthalmic Digital Health: Implandata Launches EYEMATE IOP-Tracking Service for Remote Monitoring and Improved Glaucoma Care	06/08/2020
Cellbox Solutions Appoints Dr. Herbert Mueller-Hartmann as Head of Research and Development	06/05/2020

Page 20 of 84